5%+ stake, activist

Tevogen (TVGN): Saadi Ryan H. disclosed a 91.1% stake in TVGN and may seek to influence the company 91.1%

Saadi Ryan H. disclosed a 91.1% stake in TVGN and may seek to influence the company.

91.1%
Stake
61.7M
Shares owned
Stake as of
Nov 2, 2026
Filed
Nov 4, 2026

What stands out in this filing

  • Reported stake 91.1% (61,709,567 shares).
  • A 13D is filed by an owner of more than 5% who may seek to influence the company.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 14, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 14, 2026 (the “Grant Date”), Tevogen Inc. (the “Company”) granted the Company’s executive officers restricted stock awards (the “RSAs”) under the Tevogen Inc. 2024 Omnibus Incentive Plan (the “Plan”), in each case consisting of shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), subject to terms and restrictions set forth in an RSA agreement with the executive officer…”
  2. Oct 27, 2026Company filing · Form 8-K · Material agreement, New debtChanged a top executive or board member, and signed an important agreement (and 2 more items)“On November 2, 2026 (the “Grant Date”), Tevogen Inc. (the “Company”) granted Ryan Saadi, Chief Executive Officer and Chairperson of the Company’s Board of Directors (the “Board”), a restricted stock award (the “RSA”) under the Tevogen Inc. 2024 Omnibus Incentive Plan (the “Plan”), covering 50,000,000 shares (“Restricted Shares”) of the Company’s common stock, par value $0.0001 per share (“Common Stock”).”
  3. Nov 2, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 2, 2026, Susan Podlogar gave notice of her resignation from service as a director of Tevogen Inc. (the “Company”), effective immediately.”

What came next

  1. Nov 4, 20265% stakeSaadi Ryan H. filed an activist stake (13D) of 91.1%
View the official recordSEC Schedule 13D

How to read SEC Schedule 13D

A Schedule 13D and a Schedule 13G both disclose beneficial ownership of more than 5% of a US company's voting shares. A 13D is the long form, filed by holders who may seek to influence or control the company, and it must state what they intend to do. A 13G is the short form, open only to passive holders and to certain institutions holding in the ordinary course of business, and it asks no question about intent.

Full guide: Schedule 13D vs Schedule 13G: what is the difference?

What else is on file for Tevogen

For Tevogen, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TVGN page.

How this filing works

Explore the data

Common questions

What does this filing report about Tevogen (TVGN) stock?

Saadi Ryan H. disclosed a 91.1% stake in TVGN and may seek to influence the company. Of the company, Schedule 13D (may seek influence).

When did it happen, and when was it made public?

Stake as of: Nov 2, 2026. Filed: Nov 4, 2026.

What stands out in this filing?

Reported stake 91.1% (61,709,567 shares). A 13D is filed by an owner of more than 5% who may seek to influence the company.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Schedule 13D, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Tevogen recently?

For Tevogen, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the TVGN page.

Does this mean TVGN stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Tevogen

Everything OQRO holds on this company is on its TVGN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data